GFAP and Alzheimer disease: Other biomarkers undergoing investigation for detecting early preclinical stages of AD, such as the shedded form of platelet-derived growth factor receptor-b and plasma glial fibrillary acidic protein, may supplement existing biomarkers in detecting epileptic preclinical or prodromal AD (16, 76).